To get more insight into the systemic consequences of Ebag9 deletion in a model of chronic antigen stimulation, we used the transgenic Eμ-Tcl1 CLL mouse model. This evidence concerns the gene EBAG9 and B-cell chronic lymphocytic leukemia.